top of page
poseidon final hero mobile.jpg

Bringing a tidal wave of change to solid tumor immunotherapy

poseidon final hero 1 oclock.jpg

Bringing a tidal wave of change to solid tumor immunotherapy

bi-specific-tcell-engager-technology.jpg

Our Mission

TCE-based immunotherapy has the potential to make waves in solid tumor treatment.

​

Poseidon’s Trident platform holds the potential of better solutions for patients.

peptide-based-solid-tumor-therapy.jpg

Our Science

The Trident T-cell engager (TCE) platform technology is:

  • Modular

  • Conditionally activated

  • Optimized for tumor penetration and retention

  • Has as an improved safety profile due to reduced cytokine production

News and Media

October 10, 2024

We are so excited to announce the publication of this article with Biopharma Dealmakers showcasing Poseidon's groundbreaking technology

Read Article
t-cell-solid-tumor-engager.jpg

POSEIDON

bottom of page